Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP716125.RAQC7vatpuDIuERGNmpOE-TsvoSaQ1D8D6D9L5StbMGZQ130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP716125.RAQC7vatpuDIuERGNmpOE-TsvoSaQ1D8D6D9L5StbMGZQ130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP716125.RAQC7vatpuDIuERGNmpOE-TsvoSaQ1D8D6D9L5StbMGZQ130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP716125.RAQC7vatpuDIuERGNmpOE-TsvoSaQ1D8D6D9L5StbMGZQ130_provenance.
- NP716125.RAQC7vatpuDIuERGNmpOE-TsvoSaQ1D8D6D9L5StbMGZQ130_assertion description "[In eight of these (80%) additional juxtapositioned nuclear factor 1, glial factor 1 and/or AP-1 binding motifs were created by duplications and/or insertions in region D. These findings indicate that type II TCRs are frequently present in PML and suggest to use TCR type II constructs for in vitro and in vivo studies of the evaluation of the functional role of DNA binding motifs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP716125.RAQC7vatpuDIuERGNmpOE-TsvoSaQ1D8D6D9L5StbMGZQ130_provenance.
- NP716125.RAQC7vatpuDIuERGNmpOE-TsvoSaQ1D8D6D9L5StbMGZQ130_assertion evidence source_evidence_literature NP716125.RAQC7vatpuDIuERGNmpOE-TsvoSaQ1D8D6D9L5StbMGZQ130_provenance.
- NP716125.RAQC7vatpuDIuERGNmpOE-TsvoSaQ1D8D6D9L5StbMGZQ130_assertion SIO_000772 11031693 NP716125.RAQC7vatpuDIuERGNmpOE-TsvoSaQ1D8D6D9L5StbMGZQ130_provenance.
- NP716125.RAQC7vatpuDIuERGNmpOE-TsvoSaQ1D8D6D9L5StbMGZQ130_assertion wasDerivedFrom befree-20140225 NP716125.RAQC7vatpuDIuERGNmpOE-TsvoSaQ1D8D6D9L5StbMGZQ130_provenance.
- NP716125.RAQC7vatpuDIuERGNmpOE-TsvoSaQ1D8D6D9L5StbMGZQ130_assertion wasGeneratedBy ECO_0000203 NP716125.RAQC7vatpuDIuERGNmpOE-TsvoSaQ1D8D6D9L5StbMGZQ130_provenance.
- befree-20140225 importedOn "2014-02-25" NP716125.RAQC7vatpuDIuERGNmpOE-TsvoSaQ1D8D6D9L5StbMGZQ130_provenance.